GLPG 1972

Drug Profile

GLPG 1972

Alternative Names: GLPG1972

Latest Information Update: 10 May 2017

Price : $50

At a glance

  • Originator Galapagos NV; Servier
  • Class Antirheumatics; Small molecules
  • Mechanism of Action ADAMTS5 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Osteoarthritis

Most Recent Events

  • 29 Apr 2017 Pharmacodynamics data from a phase I trial in Healthy volunteers released by Galapagos
  • 29 Apr 2017 Galapagos plans a phase Ib trial for Osteoarthritis in USA
  • 14 Apr 2017 Phase-I clinical trials in Osteoarthritis (In volunteers) in Belgium (PO) (NCT03143725)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top